tiprankstipranks
Dimerix Limited (AU:DXB)
ASX:DXB
Australian Market
DXB
Dimerix Limited
RESEARCH TOOLSreports
Want to see AU:DXB full AI Analyst Report?

Dimerix Limited (DXB) Stock News & Sentiment

98 Followers
Dimerix Highlights ACTION3 Trial De-Risking and Commercial Potential for DMX-200
Premium
Company Announcements
Dimerix Highlights ACTION3 Trial De-Risking and Commercial Potential for DMX-200
27d ago
DXB
Dimerix Confirms Strong Statistical Power and Refines Strategy for Phase 3 FSGS Trial
Premium
Company Announcements
Dimerix Confirms Strong Statistical Power and Refines Strategy for Phase 3 FSGS Trial
27d ago
DXB
Dimerix to Court Singapore Investors With Update on Phase 3 Kidney Drug
Premium
Company Announcements
Dimerix to Court Singapore Investors With Update on Phase 3 Kidney Drug
2M ago
DXB
Dimerix Over-Recruits in Pivotal FSGS Phase 3 Trial as Last Adult Patient Dosed
Premium
Company Announcements
Dimerix Over-Recruits in Pivotal FSGS Phase 3 Trial as Last Adult Patient Dosed
3M ago
DXB
Dimerix Courts Investors With Perth and Singapore Briefings on FSGS Phase 3 Program
Premium
Company Announcements
Dimerix Courts Investors With Perth and Singapore Briefings on FSGS Phase 3 Program
3M ago
DXB
Dimerix to Showcase Phase 3 FSGS Program at Oppenheimer Healthcare Conference
Premium
Company Announcements
Dimerix to Showcase Phase 3 FSGS Program at Oppenheimer Healthcare Conference
3M ago
DXB
Dimerix Revenue Surges but Loss Deepens and Asset Base Thins
Premium
Company Announcements
Dimerix Revenue Surges but Loss Deepens and Asset Base Thins
3M ago
DXB
More AU:DXB News >

DXB News on the Web

Health Check: Telix strikes surprise $3 billion-plus headline deal to develop next-gen therapies
StockHead
Neutral
Morgans names seven ASX healthcare stocks with upcoming catalysts
StockHead
Neutral
Dimerix to Court Singapore Investors With Update on Phase 3 Kidney Drug
TipRanks News
Bullish
Scott Power: Conflict, inflation weigh on ASX healthcare as catalysts drive focus
StockHead
Neutral
Dimerix to conduct blinded review of phase III kidney disease trial data
StockHead
Neutral
Dimerix doses final patient in Phase III kidney disease trial as enrolment exceeds target
StockHead
Neutral
Dimerix completes adult dosing in ACTION3 Phase 3 trial as enrolment tops target
Proactive Investors
Bullish
Why Dimerix Shares Are Surging On Trial Breakthrough
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
AU:DXB
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:DXB’s Media Buzz Sentiment?
1 articles about AU:DXB were published this week. In an average week, 2.25 articles are published.
    What is AU:DXB’s weekly average amount of articles?
    In an average week, 2.25 articles about AU:DXB are published.
      What is AU:DXB’s News Sentiment?
      100% of articles about AU:DXB were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week